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Classical swine fever (CSF) is a viral disease affecting both domestic pigs and wild boars 
worldwide. Outbreaks of CSF impair internal and international trade of pigs and pig products. 
Therefore, the disease is of major importance from an economic as well as welfare view. 
Effective live attenuated vaccines against CFSV are available and many of these provide 
lifelong immunity. However, the antibody response induced by these vaccines cannot be 
distinguished from that observed in naturally infected animals and therefore great efforts are 
currently focusing on the development of new DIVA vaccines allowing differentiation of infected 
from vaccinated animals.  
 
Previously, the chimeric virus vaccine, CP7_E2gif, has been presented as a safe live DIVA 
vaccine candidate against CSF (Rasmussen et al., 2007). CP7_E2gif is unique as no CSFV 
sequence is present in the genome. Thus, the backbone consists of Bovine viral diarrhoea 
(BVDV) strain CP7 of which the envelope protein E2 has been replaced with E2 from Border 
disease virus (BDV) strain Gifhorn. Therefore, CSFV E2 specific DIVA detection is an option 
(Rasmussen et al., 2008; Rasmussen et al 2009).  
 
The aim of the present study was to further evaluate the DIVA specificity of the chimeric 
pestivirus CP7_E2gif compared to the C-strain “Riems” conventional live attenuated vaccine. 
Two groups of 12 pigs were vaccinated by intramuscular injection with each of the 2 vaccines, 
respectively, and the serological response was measured twice weekly up to 28 days after 
vaccination. Furthermore, the pigs were monitored daily for general health status, clinical signs 
of disease and body temperatures. Necropsy with special focus on pathological changes, which 
could be linked to the vaccination, was carried out on 3 pigs every week from post vaccination 
day (PVD) 7 to 28. After vaccination, all 24 pigs remained healthy as neither clinical, 
pathological nor body temperature changes were observed. Seroconversion, measured by a 
routine blocking CSFV ELISA, could be observed from day 14 post vaccination in pigs 
vaccinated with C-strain. In contrast, CP7_E2gif vaccinated pigs were not tested antibody 
positive during the 28 days period. Further analyses for BDV and CSFV E2 specific antibodies in 
serum samples from the vaccinated pigs as well as for the presence of neutralizing antibodies 
against CSFV, BVDV and BDV are in progress and these results will be presented at the 
meeting.  
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